SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-001520
Filing Date
2022-03-08
Accepted
2022-03-08 16:37:20
Documents
59
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q avid_i10q-013122.htm   iXBRL 10-Q 771237
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER avid_ex-3101.htm EX-31.1 9627
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER avid_ex-3102.htm EX-31.2 9710
4 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER avid_ex-3200.htm EX-32 6080
  Complete submission text file 0001683168-22-001520.txt   4305650

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdmo-20220131.xsd EX-101.SCH 29190
6 XBRL CALCULATION FILE cdmo-20220131_cal.xml EX-101.CAL 47669
7 XBRL DEFINITION FILE cdmo-20220131_def.xml EX-101.DEF 134666
8 XBRL LABEL FILE cdmo-20220131_lab.xml EX-101.LAB 287838
9 XBRL PRESENTATION FILE cdmo-20220131_pre.xml EX-101.PRE 244986
53 EXTRACTED XBRL INSTANCE DOCUMENT avid_i10q-013122_htm.xml XML 653543
Mailing Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780
Business Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 22722212
SIC: 2834 Pharmaceutical Preparations